Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank94
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Latest
70.48%
↑ 841% vs avg
Percentile
P94
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
7.49%
Historical baseline
PeriodValue
Q4 202570.48%
Q3 2025-6.11%
Q2 2025-5.69%
Q1 2025-6.93%
Q4 2024-6.56%
Q3 2024-5.18%
Q2 202426.51%
Q1 2024-9.74%
Q4 2023-7.60%
Q3 2023-7.14%
Q2 2023-6.47%
Q1 202341.66%
Q4 2022-8.52%
Q3 202226.93%
Q2 2022-11.36%
Q1 2022-6.28%
Q4 2021-8.04%
Q3 202185.34%
Q2 2021-11.88%
Q1 202120.76%
Q4 2020-8.89%
Q3 2020-1.83%
Q2 202052.72%
Q1 2020-14.11%
Q4 2019-4.76%
Q3 201977.98%
Q2 2019-13.81%
Q1 2019-11.87%
Q4 20180.00%
Q3 20180.00%
Q2 20180.00%
Q1 20180.00%